For the quarter ended October 2025, HealthEquity (HQY) reported revenue of $322.16 million, up 7.2% over the same period last year. EPS came in at $1.01, compared to $0.78 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $319.96 million, representing a surprise of +0.69%. The company delivered an EPS surprise of +12.22%, with the consensus EPS estimate being $0.90.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Total HSA Assets: $34.45 billion compared to the $33.68 billion average estimate based on three analysts.
- HSA Assets - HSA investments: $17.54 billion versus $16.22 billion estimated by three analysts on average.
- Total Accounts - CDBs: 7.17 million versus 7.05 million estimated by three analysts on average.
- Total Accounts: 17.28 million compared to the 17.26 million average estimate based on three analysts.
- HSA Assets - HSA cash: $16.91 billion versus $17.43 billion estimated by three analysts on average.
- Total Accounts - HSAs: 10.11 million versus the three-analyst average estimate of 10.21 million.
- Revenue- Service: $120.29 million versus the three-analyst average estimate of $119.5 million. The reported number represents a year-over-year change of +0.9%.
- Revenue- Custodial: $159.07 million compared to the $156.61 million average estimate based on three analysts. The reported number represents a change of +12.9% year over year.
- Revenue- Interchange: $42.81 million versus $42.88 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.2% change.
View all Key Company Metrics for HealthEquity here>>>
Shares of HealthEquity have returned +4.1% over the past month versus the Zacks S&P 500 composite's -0.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HealthEquity, Inc. (HQY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
